Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Liver Transpl. 2019 Sep 19;25(12):1747–1755. doi: 10.1002/lt.25630

Table 3-.

Predictive Value of the Scoring System Obtained from the Validation Group*

Low cutoff point (<2.6) Indeterminate (2.6–4.6) High cutoff point (>4.6) Total
Total 6434 21108 4267 31809**
No Incident PVT 6011 1895 4267 29213
Incident PVT 432 1895 278 2596
Sensitivity 85% 9%
Specificity 36% 100%
Positive predictive value 16% 85%
Negative predictive value 94% 88%
Likelihood ratio (+) 1.3 38.8
Likelihood ratio (−) 0.4 0.9
Interpretation PVT will not develop over next 12 months (94% certainty) PVT will develop over next 12 months (85% certainty)
*

Incident PVT was 8.2% in the validation group.

**

PVT-RI unable to be calculated for eight recipients due to missing data